Skip to main content
Publications
Forns J, Dudukina E, Hagg D, Szentkuti P, Gembert K, Plana E, Gilsenan A, Horvath-Puho E, Ehrenstein V, Reutfors J, Rebordosa C. Risk of major cardiovascular and cerebrovascular events in users of lisdexamfetamine and other medications for attention-deficit/hyperactivity disorder in Denmark and Sweden: a population-based cohort study. Neurol Ther. 2022 Dec 1;11(4):1659-76. doi: 10.1007/s40120-022-00396-y
Mortamais M, Pujol J, van Drooge BL, Macia D, Martinez-Vilavella G, Reynes C, Sabatier R, Rivas I, Grimalt J, Forns J, Alvarez-Pedrerol M, Querol X, Sunyer J. Effect of exposure to polycyclic aromatic hydrocarbons on basal ganglia and attention-deficit hyperactivity disorder symptoms in primary school children. Environ Int. 2017 Aug;105:12-9. doi: 10.1016/j.envint.2017.04.011
Suades-Gonzalez E, Forns J, Garcia-Esteban R, Lopez-Vicente M, Esnaola M, Alvarez-Pedrerol M, Julvez J, Caceres A, Basagana X, Lopez-Sala A, Sunyer J. A longitudinal study on attention development in primary school children with and without teacher-reported symptoms of ADHD. Front Psychol. 2017 May 16;8:655. doi: 10.3389/fpsyg.2017.00655